Cargando…
A Mycobacterium tuberculosis Cytochrome bd Oxidase Mutant Is Hypersensitive to Bedaquiline
The new medicinal compound bedaquiline (BDQ) kills Mycobacterium tuberculosis by inhibiting F(1)F(o)-ATP synthase. BDQ is bacteriostatic for 4 to 7 days and kills relatively slowly compared to other frontline tuberculosis (TB) drugs. Here we show that killing with BDQ can be improved significantly b...
Autores principales: | Berney, Michael, Hartman, Travis E., Jacobs, William R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Microbiology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161257/ https://www.ncbi.nlm.nih.gov/pubmed/25028424 http://dx.doi.org/10.1128/mBio.01275-14 |
Ejemplares similares
-
Cytochrome bd Oxidase and Hydrogen Peroxide Resistance in Mycobacterium tuberculosis
por: Forte, Elena, et al.
Publicado: (2013) -
Host immunity increases Mycobacterium tuberculosis reliance on cytochrome bd oxidase
por: Cai, Yi, et al.
Publicado: (2021) -
Sterilization by Adaptive Immunity of a Conditionally Persistent Mutant of Mycobacterium tuberculosis
por: Vilchèze, Catherine, et al.
Publicado: (2021) -
An amiloride derivative is active against the F(1)F(o)-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis
por: Hards, Kiel, et al.
Publicado: (2022) -
Molecular Evolution of Cytochrome bd Oxidases across Proteobacterial Genomes
por: Degli Esposti, Mauro, et al.
Publicado: (2015)